| Literature DB >> 29607886 |
Fuminari Miura1,2, Ryota Matsuyama1,3, Hiroshi Nishiura1,3.
Abstract
BACKGROUND: Foodborne norovirus outbreak data in Japan from 2005-2006, involving virological surveillance of all symptomatic and asymptomatic individuals, were reanalyzed to estimate the asymptomatic ratio of norovirus infection along with the risk of infection and the probability of virus shedding.Entities:
Keywords: Caliciviridae; Norwalk virus; asymptomatic ratio; mathematical model; statistical estimation; subclinical infection
Mesh:
Year: 2018 PMID: 29607886 PMCID: PMC6111106 DOI: 10.2188/jea.JE20170040
Source DB: PubMed Journal: J Epidemiol ISSN: 0917-5040 Impact factor: 3.211
Figure 1. Symptomatic and asymptomatic individuals during foodborne norovirus-outbreaks in Japan from 2005 through 2006. Extracted from Ozawa et al (2007).[31] Setting No. corresponds to identity numbers given by original research. No. of individuals stands for the total number of individuals diagnosed by stool specimen test at each outbreak setting. Left five bars show the genogroup I (GI)-associated outbreaks. Other 50 bars show the genogroup II (GII)-associated outbreaks, and middle of them emphasize outbreaks caused by the genogroup II type 4 (GII4) norovirus, which is the most dominant among genotypes extracted from acute gastroenteritis patients.
Figure 2. Data generation process of infection, symptomatic illness and virus testing results during norovirus outbreaks in Japan. (+) and (−) represent virus testing result of stool specimens being positive and negative, respectively. p, s and q represent the probabilities of infection, asymptomatic infection given infection, and test positive outcome, respectively.
Estimated risk of infection (p), asymptomatic infection given successful infection (s) and virus positive outcomes of stool sample (q)
| Grouped genotypes | Risk of infection (%) | Risk of asymptomatic infection (%) | Risk of virus positive outcome (%) |
| GI+GII (All) | 25.4 (23.4, 27.4) | 32.1 (27.7, 36.7) | 73.2 (68.6, 77.4) |
| GI (All) | 45.2 (32.6, 61.8) | 44.0 (25.8, 63.3) | 70.0 (48.3, 86.8) |
| GI 3 | 58.8 (29.4, 141.6) | 50.0 (15.6, 84.4) | 60.0 (19.9, 91.9) |
| GI 14 | 75.0 (24.3, NA) | 66.7 (16.1, 97.7) | 50.0 (3.8, 96.2) |
| GII (All) | 24.7 (22.7, 26.7) | 31.4 (26.9, 36.1) | 73.4 (68.7, 77.7) |
| GII 1 | 60.0 (34.2, 94.6) | 37.5 (11.0, 71.0) | 83.3 (44.6, 99.0) |
| GII 2 | 93.8 (58.6, 146.8) | 33.3 (6.5, 71.9) | 80.0 (37.2, 98.7) |
| GII 3 | 34.9 (27.2, 43.6) | 22.2 (10.8, 37.4) | 62.2 (47.7, 75.4) |
| GII 4 | 18.4 (15.9, 21.3) | 40.7 (32.8, 49.0) | 68.0 (59.4, 75.9) |
Profile likelihood based 95% confidence intervals are shown in parentheses.
NA (in an upper uncertainty bound) stands for the result which could not converge in our computing due to the sample size.
Figure 3. Comparison between observed and predicted number of people by symptom and PCR testing result. A) Results from genogroup-combined model with three parameters. B and C) Genogroup-separated modelling results with a total of six parameters.
Figure 4. Sensitivity of estimated probabilities to the relative risk (alpha) of virus shedding among asymptomatic infected individuals compared with symptomatic cases. The value of alpha, defined as the ratio of the probability of shedding virus by an asymptomatic individual to the one by a symptomatic individual, was varied from 0.5 to 1.0 (baseline).